Musical Training Programme to Improve Neurocognitive Functioning of Children Surviving Brain Tumours

Sponsor
The Hong Kong Polytechnic University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05202925
Collaborator
Health and Medical Research Fund (Other)
40
1
1
27.9
1.4

Study Details

Study Description

Brief Summary

We aim to conduct a feasibility study to determine the feasibility and suitability of implementing a musical training program for children surviving brain tumours. This study will demonstrate the feasibility of implementing a musical training program in improving the neurocognitive functioning of surviving brain tumours.

Condition or Disease Intervention/Treatment Phase
  • Other: Musical Training Program
N/A

Detailed Description

Brain tumour is the second most common childhood cancer in Hong Kong. Evidence shows that cancer and its treatments have long-term and lasting adverse effects on the neurocognitive functioning of paediatric brain tumour survivors, including the impairment of intellectual development and deficits in attention, working memory, processing speed and executive functions. There has been an increase in the use of musical training to promote the neuro-rehabilitation of patients suffering from stroke and Parkinson's disease, and to improve reading skills and academic achievement in young poor readers, and to enhance children's cognitive development. We conducted a randomized controlled trial (RCT) from 2017 to 2018 to examine the effectiveness of musical training on psychological outcomes and quality of life in Chinese paediatric brain tumour survivors. The results showed that participants who received a weekly 45-min lesson on musical training for 52 weeks (intervention group) reported statistically significant fewer depressive symptoms, higher levels of self-esteem, and better quality of life than those who received placebo intervention (control group) at 12-month demonstrating the effectiveness of musical training intervention. Nevertheless, it is unclear whether musical training can also be used to improve neurocognitive functioning, in particular the attention, processing speed, and executive functions of children surviving brain tumours.

The overall aim of this proposed study will be to assess the feasibility of a musical training program in improving the neurocognitive functioning of children surviving brain tumours. The objectives of this feasibility study are as follows:

  1. To ascertain the feasibility of recruitment and data collection in the outpatient clinic of the Hong Kong Children's Hospital;

  2. To assess the response and retention rates of the study;

  3. To examine the content of the proposed musical training program for its appropriateness, comprehensiveness and duration to the target participants;

  4. To evaluate the appropriateness and feasibility of using various assessment tools in measuring the intelligence, attention, processing speed and executive functions of the paediatric brain tumour survivors; and

  5. To assess any changes in neurocognitive functioning of children surviving brain tumours after receiving musical training for 52 weeks.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Feasibility Study of a Musical Training Program in Improving the Neurocognitive Functioning of Children Surviving Brain Tumours
Actual Study Start Date :
Oct 1, 2021
Anticipated Primary Completion Date :
Oct 1, 2023
Anticipated Study Completion Date :
Jan 27, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Musical Training

All subjects in the intervention group will receive a weekly 45-minute lesson, one-to-one musical training for 52 weeks.

Other: Musical Training Program
a weekly 45-minute lesson, one-to-one musical training

Outcome Measures

Primary Outcome Measures

  1. Recruitment rate of the study [at baseline before the start of the intervention]

    the proportion of subjects who are eligible and invited and consent to participate.

  2. Response rate of the study [at baseline and 12 months after starting the intervention]

    The proportion of subjects who complete the questionnaires and assessments at baseline and 12 months after starting the intervention

  3. Retention rate of the study [at baseline and 12 months after starting the intervention]

    The proportion of subjects who complete the whole intervention from baseline to 12 months.

Secondary Outcome Measures

  1. Nonverbal intelligence scores of the subject [at baseline and 12 months after starting the intervention]

    Measured by the Test of Nonverbal Intelligence, 4th edition (TONI-4)

  2. Attention scores of the subject [at baseline and 12 months after starting the intervention]

    Measured by the Digit Span

  3. Processing speed scores of the subject [at baseline and 12 months after starting the intervention]

    Measured by the Children's Color Trails Test (CCTT)

  4. Executive functions scores of the subject [at baseline and 12 months after starting the intervention]

    Measured by the Children's Color Trails Test (CCTT)

Eligibility Criteria

Criteria

Ages Eligible for Study:
7 Years to 16 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. children who have completed cancer treatment at least 2 months previously;

  2. aged between 7 and 16 years,

  3. able to speak Cantonese and read Chinese, and

  4. those who have not undertaken any musical training following their cancer diagnosis.

Exclusion Criteria:
  1. those survivors with evidence of cancer recurrence or second malignancy in their medical records

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Hong Kong Children's Hospital Hong Kong Hong Kong

Sponsors and Collaborators

  • The Hong Kong Polytechnic University
  • Health and Medical Research Fund

Investigators

  • Principal Investigator: Joyce Chung, The Hong Kong Polytechnic University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dr Joyce Chung, Assistant Professor, School of Nursing, The Hong Kong Polytechnic University
ClinicalTrials.gov Identifier:
NCT05202925
Other Study ID Numbers:
  • HKCH-REC-2021-008
First Posted:
Jan 24, 2022
Last Update Posted:
Jan 24, 2022
Last Verified:
Jan 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 24, 2022